Cook eyes peripheral arteries in new stab at DES (drug-eluting stents) sector
This article was originally published in Clinica
After failing in recent years to establish itself among the key sellers of drug-eluting stents (DES) for coronary artery disease, Cook is looking towards the peripheral artery market as a means of cashing in on the spoils promised by DES technology.
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
While analysts are struggling to look further than generic competition facing the French firm's best-seller Somatuline, new chief David Loew tells Scrip that intelligent lifecycle management and focused external deals will drive Ipsen's growth.
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.